The Transactions Affinity Group highlights the structural, corporate, securities, regulatory, tax, and accounting issues implicated in merger and acquisition transactions, all with an emphasis on features that are unique to deals in the health care industry. Despite the difficult economic climate caused by the collapse of the credit markets, health care transactions continue to close. In fact, many in the industry believe that the lack of credit may accelerate deal activity, as poorly capitalized, unprofitable institutions are forced to seek partners or buyers. The Transactions Affinity Group focuses on developments in deals prevalent in the health care industry, from hospital acquisitions and dispositions, to consolidations in the pharmaceutical industry, to joint ventures and other arrangements among the service providers, biotechnology/pharmaceutical companies, and payers. The Affinity Group covers case law developments highlighting decisions that will shape the way transactions are structured and consummated, follows developments in financing and capitalizing for-profit and nonprofit providers, and highlights select bankruptcy law matters that impact health care transactions.